Hooman Rashidi, MD
- Call 216.444.3064
Additional Locations
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Hooman Rashidi, MD
Dr. Rashidi’s experience in bioinformatics dates back to his graduate years at UCSD which subsequently allowed him to also serve as the principle author and editor of several popular bioinformatics textbooks. This background has also enabled him to develop various novel ML platforms. Before joining the Cleveland Clinic as the Director of PLMI’s Center for Artificial Intelligence and Data Science, he served as the Director of AI for University of California Davis Medical Center and Professor & Vice chair of informatics and Computational pathology (until Dec 2021), leading multiple active and exciting AI / ML research in various clinical, educational, and quality improvement areas with over 30 collaborators from multiple departments and various prominent institutions. These studies also led to numerous manuscripts in which he serves as the senior/corresponding author (most recent of which published in Nature’s Scientific Reports and Plos One) and also has led to several filed patents. His most exciting and newest invention is the unique/ proprietary Automated Machine Learning (Auto-ML) software known as MILO (Machine Intelligence Learning Optimizer). MILO”s suite of applications includes it’s powerful Auto-ML platform and 6 unique complimentary preprocessing and statistics Apps which have been licensed to several industry and academic institutions and serving as a powerful suite of data science tools for a large number of clinical, quality and educational projects.
In addition to the above, Dr. Rashidi is also a known educator and the co-founder, developer, and senior editor of HematologyOutlines, a very popular online hematology atlas that is used internationally by medical schools and other training programs and endorsed by the American Society of Clinical Pathology for clinical laboratory scientist and medical technologist training.
Dr. Rashidi’s efforts in the digital space and machine learning are widely recognized nationally and internationally, as evidenced by his various national and international talk invites (at numerous prestigious conferences / institutions), his numerous editorial and reviewer roles, his numerous invited review articles in prominent journals along with his various national and local committee roles within this space.
Education & Professional Highlights
Appointed
2022
Education & Fellowships
Fellowship - UCLA David Geffen School of Medicine & UCLA Health System
Hematopathology
Los Angeles,
CA USA
2009
Residency - Yale New Haven Medical Center & School of Medicine
Anatomic and Clinical Pathology
New Haven,
CT USA
2008
Internship - Beth Israel Deaconess Medical Center and Harvard Medical School
Internal Medicine
Boston,
MA USA
2004
Medical Education - University of Texas Health Science Center at San Antonio - School of Medicine
San Antonio,
TX USA
2003
Graduate School - University of California San Diego
Biology
La Jolla,
CA USA
1998
Undergraduate - University of California San Diego
Biochemistry
La Jolla,
CA USA
1997
Certifications
- Pathology - Hematopathology
- Pathology - Anatomic & Clinical Pathology
Research & Publications
See publications for Hooman Rashidi, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 2/15/2022, Dr. Rashidi has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
